ADIPOTIDE 10 MG INJECTION
Drug Class: Targeted Apoptotic Peptide
Composition:
- Active Substance: Adipotide (FTPP)
- Concentration: 10 mg per vial
Presentation: 2 mL Glass Vial
Form: Lyophilized (Freeze-Dried) Powder
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
While most fat-loss compounds work indirectly through appetite suppression or metabolic enhancement, what if you could target and eliminate fat cells directly? Peptide Hubs presents Adipotide for sale, a groundbreaking research compound that represents a paradigm shift in fat reduction technology. Also known as FTPP (Fat-Targeted Proapoptotic Peptide), our Peptide Hubs FTPP is a 10 mg lyophilized powder that works through a unique mechanism of action: inducing programmed cell death (apoptosis) specifically in white adipose tissue. For researchers seeking the next frontier in physique enhancement, Adipotide offers a direct approach to stubborn fat deposits that resist traditional methods.
Adipotide is a novel, synthetically designed peptide conjugate that functions as a targeted apoptotic agent. Its mechanism is fundamentally different from any other fat-loss compound. It consists of a targeting moiety that binds specifically to two proteins (prohibitin and ANXA2) that are highly expressed on the blood vessels supplying white fat cells. Once bound, it delivers a pro-apoptotic synthetic peptide that triggers programmed cell death in the endothelial cells of these blood vessels. This cuts off the blood supply (nutrition and oxygen) to the fat cells, causing them to shrivel and die. The body's natural cleanup crew (macrophages) then removes the cellular debris. This targeted approach means it can potentially address specific fat deposits that are genetically determined and notoriously difficult to lose.

Research with Adipotide 10 mg has demonstrated several remarkable effects that are of significant interest to the physique enhancement community:
Dosing for Adipotide is a critical aspect of research due to its potent and targeted nature. As an advanced research compound, protocols are still being refined. Literature suggests dosages in the range of 0.5 mg to 2.0 mg per day for a limited duration. It is typically reconstituted with bacteriostatic water. A crucial aspect of its administration is that it is often used in a localized, subcutaneous manner, injected directly into the subcutaneous fat layer of the target area (e.g., abdomen). The 10 mg vial provides a substantial supply for a focused research cycle. Extreme caution and consultation with a healthcare professional are mandatory before considering research with this compound.
Research cycles for Adipotide are typically very short due to its powerful effects and potential for side effects. Cycles of 7 to 21 days are common in literature, followed by a significant break. It can be part of a strategic research stack with other Peptide Hubs products for comprehensive body composition management:
Adipotide is a powerful research compound with a distinct side effect profile that requires careful consideration. Reported effects in research models include:
This is an advanced research chemical and should be treated with extreme caution. Sourcing from a reputable supplier like Peptide Hubs is critical for ensuring product purity and accurate dosing, which is non-negotiable for safety. Comprehensive health monitoring, especially of kidney function, is essential during any research involving Adipotide.
In theory, yes, for the specific fat cells that are destroyed. Unlike fat loss from dieting where fat cells simply shrink, Adipotide induces apoptosis, meaning those cells are permanently eliminated. However, remaining fat cells can still hypertrophy (enlarge) if a caloric surplus is maintained post-cycle, and new fat cells can still be formed from preadipocytes. Therefore, permanent results are dependent on maintaining a proper diet and lifestyle after the research cycle.
The short cycles are primarily a safety precaution due to the observed, reversible kidney toxicity in research models. Limiting the duration of exposure helps manage this risk and allows the body to recover fully between cycles. The potent effects also mean that longer cycles are not necessary to achieve significant results.
Yes, this is one of its most unique potential applications. Because it is often administered via localized subcutaneous injection, researchers can target specific adipose deposits. However, it's important to understand that some systemic distribution will occur, and the compound's affinity for white fat vasculature means it will have effects beyond just the injection site, though the greatest effect is typically local.
They are completely different. Semaglutide and Tirzepatide are GLP-1 receptor agonists that work primarily by suppressing appetite and slowing gastric emptying, leading to reduced caloric intake. Adipotide does not affect appetite; it directly destroys fat cells by cutting off their blood supply. One works on the brain/gut (Semaglutide/Tirzepatide), while the other works directly on the fat tissue itself (Adipotide). They represent two entirely different classes of fat-loss compounds.
Please log in to write Adipotide (FTPP) 10 mg review.
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report